中华心血管病杂志
中華心血管病雜誌
중화심혈관병잡지
Chinese Journal of Cardiology
2011年
5期
397-401
,共5页
张丹%葛蕾%李静%李希%冯芳%CHEN Yi-ping%CHEN Zheng-ming%Landray Martin%Armitage Jane%CHEN Fang%蒋立新%代表第二项以及保护研究协作组
張丹%葛蕾%李靜%李希%馮芳%CHEN Yi-ping%CHEN Zheng-ming%Landray Martin%Armitage Jane%CHEN Fang%蔣立新%代錶第二項以及保護研究協作組
장단%갈뢰%리정%리희%풍방%CHEN Yi-ping%CHEN Zheng-ming%Landray Martin%Armitage Jane%CHEN Fang%장립신%대표제이항이급보호연구협작조
动脉粥样硬化%脑血管意外%降血脂药%二级预防
動脈粥樣硬化%腦血管意外%降血脂藥%二級預防
동맥죽양경화%뇌혈관의외%강혈지약%이급예방
Atherosclerotic disease%Cerebrovascular accident%Lipid regulating drugs%Secondary prevention
目的 了解中国动脉粥样硬化性心脑血管病患者他汀类药物的使用现状,分析影响用药的相关因素.方法 借助一项国际多中心大规模临床试验在中国实施之际,从10个城市的39家三级医院中筛查动脉粥样硬化性心脑血管病调查对象11 783例,利用电子问卷采集基线资料,对其中的他汀类药物使用情况进行统计和分析.结果 接受调查的动脉粥样硬化性心脑血管病患者中,7022例(59.6%)未服用他汀类药物,即使是在4761例服药者中,仍有1120例(23.5%)的调查对象用药持续时间明显短于其罹患动脉粥样硬化性心脑血管病的病史时间.6198例冠心病调查对象(无动脉粥样硬化性缺血性卒中病史)服用他汀的有3668例(59.2%),5585例动脉粥样硬化性缺血性卒中调查对象应用他汀有1093例(19.6%),动脉粥样硬化性缺血性卒中患者的应用比例是冠心病患者的33.1%.结论 目前国内动脉粥样硬化性心脑血管病患者他汀类药物的使用严重不足,尤以动脉粥样硬化性缺血性卒中为甚,应予以高度重视.
目的 瞭解中國動脈粥樣硬化性心腦血管病患者他汀類藥物的使用現狀,分析影響用藥的相關因素.方法 藉助一項國際多中心大規模臨床試驗在中國實施之際,從10箇城市的39傢三級醫院中篩查動脈粥樣硬化性心腦血管病調查對象11 783例,利用電子問捲採集基線資料,對其中的他汀類藥物使用情況進行統計和分析.結果 接受調查的動脈粥樣硬化性心腦血管病患者中,7022例(59.6%)未服用他汀類藥物,即使是在4761例服藥者中,仍有1120例(23.5%)的調查對象用藥持續時間明顯短于其罹患動脈粥樣硬化性心腦血管病的病史時間.6198例冠心病調查對象(無動脈粥樣硬化性缺血性卒中病史)服用他汀的有3668例(59.2%),5585例動脈粥樣硬化性缺血性卒中調查對象應用他汀有1093例(19.6%),動脈粥樣硬化性缺血性卒中患者的應用比例是冠心病患者的33.1%.結論 目前國內動脈粥樣硬化性心腦血管病患者他汀類藥物的使用嚴重不足,尤以動脈粥樣硬化性缺血性卒中為甚,應予以高度重視.
목적 료해중국동맥죽양경화성심뇌혈관병환자타정류약물적사용현상,분석영향용약적상관인소.방법 차조일항국제다중심대규모림상시험재중국실시지제,종10개성시적39가삼급의원중사사동맥죽양경화성심뇌혈관병조사대상11 783례,이용전자문권채집기선자료,대기중적타정류약물사용정황진행통계화분석.결과 접수조사적동맥죽양경화성심뇌혈관병환자중,7022례(59.6%)미복용타정류약물,즉사시재4761례복약자중,잉유1120례(23.5%)적조사대상용약지속시간명현단우기리환동맥죽양경화성심뇌혈관병적병사시간.6198례관심병조사대상(무동맥죽양경화성결혈성졸중병사)복용타정적유3668례(59.2%),5585례동맥죽양경화성결혈성졸중조사대상응용타정유1093례(19.6%),동맥죽양경화성결혈성졸중환자적응용비례시관심병환자적33.1%.결론 목전국내동맥죽양경화성심뇌혈관병환자타정류약물적사용엄중불족,우이동맥죽양경화성결혈성졸중위심,응여이고도중시.
Objective To investigate the current statin use among high-risk patients with atherosclerotic cardiovascular diseases in Chinese large hospitals.Methods Clinical history and current medication were recorded in 11 783 patients with a history of atherosclerotic cardiovascular disease(CVD)from 39 highest-ranking hospitals in 10 Chinese cities.Results Indication for statin use was given for all screened patients and statin was not prescribed in up to 59.6% (7022)patients. For patients with statin use, medication time was shorter than their atherosclerotic CVD history in 1120 (23.5%) patients. The proportion of statin use among patients with ischemic stroke was 19.6%,among patients with coronary heart disease without ischemic stroke was 59.2%.Conclusion Statin is underused in secondary prevention among patients with atherosclerotic CVD in China.There is a large gap between guideline recommended statin use and in practice.Thus,it remains a major challenge for healthcare professionals and policy makers to resolve this problem rapidly.
